These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 38346385)

  • 41. Contemporary Imaging Assessment of Strictures and Fibrosis in Crohn Disease, With Focus on Quantitative Biomarkers: From the
    Rimola J; Beek KJ; Ordás I; Gecse KB; Cuatrecasas M; Stoker J
    AJR Am J Roentgenol; 2024 Apr; 222(4):e2329693. PubMed ID: 37530400
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Strictures in Crohn's Disease: From Pathophysiology to Treatment.
    Crespi M; Dulbecco P; De Ceglie A; Conio M
    Dig Dis Sci; 2020 Jul; 65(7):1904-1916. PubMed ID: 32279173
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Comparison of Three Magnetization Transfer Ratio Parameters for Assessment of Intestinal Fibrosis in Patients with Crohn's Disease.
    Meng J; Huang S; Sun C; Zhang ZW; Mao R; Yang YH; Feng ST; Li ZP; Li X
    Korean J Radiol; 2020 Mar; 21(3):290-297. PubMed ID: 32090521
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Metabolic modulation during intestinal fibrosis.
    Bos S; Laukens D
    J Dig Dis; 2020 Jun; 21(6):319-325. PubMed ID: 32406133
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Endoscopic Stricturotomy and Strictureplasty.
    Navaneethan U; Lourdusamy D
    Gastrointest Endosc Clin N Am; 2022 Oct; 32(4):687-697. PubMed ID: 36202510
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Ultrasound Shear Wave Elastography and Contrast Enhancement: Effective Biomarkers in Crohn's Disease Strictures.
    Lu C; Gui X; Chen W; Fung T; Novak K; Wilson SR
    Inflamm Bowel Dis; 2017 Mar; 23(3):421-430. PubMed ID: 28129289
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The Potential of Radiomics in the Assessment of Intestinal Fibrosis in Crohn's Disease.
    Zhang B; Zhang S
    Gastroenterology; 2021 Dec; 161(6):2065-2066. PubMed ID: 34175278
    [No Abstract]   [Full Text] [Related]  

  • 48. Measurement of Fibrosis in Crohn's Disease Strictures with Imaging and Blood Biomarkers to Inform Clinical Decisions.
    Higgins PD
    Dig Dis; 2017; 35(1-2):32-37. PubMed ID: 28147365
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Revisiting fibrosis in inflammatory bowel disease: the gut thickens.
    D'Alessio S; Ungaro F; Noviello D; Lovisa S; Peyrin-Biroulet L; Danese S
    Nat Rev Gastroenterol Hepatol; 2022 Mar; 19(3):169-184. PubMed ID: 34876680
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Molecular Imaging in Inflammatory Bowel Disease.
    Noriega-Álvarez E; Martín-Comín J
    Semin Nucl Med; 2023 Mar; 53(2):273-286. PubMed ID: 36702729
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Association of Circulating Fibrocytes With Fibrostenotic Small Bowel Crohn's Disease.
    Ueno A; Jijon HB; Peng R; Sparksman S; Mainoli B; Filyk A; Li Y; Wilson S; Novak K; Panaccione R; Hirota S; Dufour A; Lu C; Beck PL
    Inflamm Bowel Dis; 2022 Feb; 28(2):246-258. PubMed ID: 34428284
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Recent advances in intestinal fibrosis.
    Lenti MV; Santacroce G; Broglio G; Rossi CM; Di Sabatino A
    Mol Aspects Med; 2024 Apr; 96():101251. PubMed ID: 38359700
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Computed tomography enterography findings correlate with tissue inflammation, not fibrosis in resected small bowel Crohn's disease.
    Adler J; Punglia DR; Dillman JR; Polydorides AD; Dave M; Al-Hawary MM; Platt JF; McKenna BJ; Zimmermann EM
    Inflamm Bowel Dis; 2012 May; 18(5):849-56. PubMed ID: 21710535
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Anti-fibrotic Drugs for Crohn's Disease: Ready for Prime Time?
    Argollo M; Gilardi D; Roda G; Fiorino G; Peyrin-Biroulet L; Danese S
    Curr Pharm Des; 2019; 25(1):47-56. PubMed ID: 30848192
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Validity of Contrast-enhanced Ultrasonography and Dynamic Contrast-enhanced MR Enterography in the Assessment of Transmural Activity and Fibrosis in Crohn's Disease.
    Wilkens R; Hagemann-Madsen RH; Peters DA; Nielsen AH; Nørager CB; Glerup H; Krogh K
    J Crohns Colitis; 2018 Jan; 12(1):48-56. PubMed ID: 28981627
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Quantitative apparent diffusion coefficient (ADC) values as an imaging biomarker for fibrosis in pediatric Crohn's disease: preliminary experience.
    Kovanlikaya A; Beneck D; Rose M; Renjen P; Dunning A; Solomon A; Sockolow R; Brill PW
    Abdom Imaging; 2015 Jun; 40(5):1068-74. PubMed ID: 25248794
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Reverse translation approach generates a signature of penetrating fibrosis in Crohn's disease that is associated with anti-TNF response.
    Xiong S; Whitehurst CE; Li L; Heo GS; Lai CW; Jain U; Muegge BD; Espenschied ST; Musich RJ; Chen M; Liu Y; Liu TC; Stappenbeck TS
    Gut; 2022 Jul; 71(7):1289-1301. PubMed ID: 34261752
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Prevalence of Bowel Damage Assessed by Cross-Sectional Imaging in Early Crohn's Disease and its Impact on Disease Outcome.
    Fiorino G; Morin M; Bonovas S; Bonifacio C; Spinelli A; Germain A; Laurent V; Zallot C; Peyrin-Biroulet L; Danese S
    J Crohns Colitis; 2017 Mar; 11(3):274-280. PubMed ID: 27799269
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Evolving roles of cross-sectional imaging in Crohn's disease.
    Magarotto A; Orlando S; Coletta M; Conte D; Fraquelli M; Caprioli F
    Dig Liver Dis; 2016 Sep; 48(9):975-83. PubMed ID: 27338853
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Circulating fibrocytes and Crohn's disease.
    Sahebally SM; Burke JP; Chang KH; Kiernan MG; O'Connell PR; Coffey JC
    Br J Surg; 2013 Nov; 100(12):1549-56. PubMed ID: 24264775
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.